Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds
Evolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University Medicine Research has revealed that...
cancer
Mursla Bio announces promising results for EvoLiver test in liver cancer detection
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients...
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Dive Brief: Boston Scientific said Monday it has agreed to acquire Intera Oncology, which makes treatments for liver tumors primarily...
Liver cancer stem cells shown to use immune system as shield to spark disease recurrence | News Center
Liver cancer cells that rub shoulders with a class of immune cells called macrophages promote treatment-resistant recurrence of the cancer,...
Deep learning for oncologic treatment outcomes and endpoints evaluation from CT scans in liver cancer
Cohorts construction and ethicsCohort A has the official title of “RATIONALE-208: A Phase 2, Open-label, Multicenter Study to Investigate the...
Finding The Right Treatment For Liver Cancer: Expert Explains The Shift to Personalised Medicine
Liver cancer often goes unnoticed in its early stages, as its symptoms can be subtle or mistaken for other less...
